Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis
S Kumar1, S M Blake, J G Emery
1Musculoskeletal Diseases, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA 19406-0939, USA. sanjay_kumar-1@gsk.com
Abstract:
Recent advances in our understanding of cellular and molecular mechanisms of rheumatoid arthritis have highlighted a critical role for interleukin-1 and tumor necrosis factor alpha. The quest for chemically amenable targets has recently led to the identification and characterization of the intracellular signaling pathways associated with these inflammatory cytokines. In particular the mitogen-activated protein kinase pathway, the nuclear factor kappaB pathway and the cross-talk between these offer several potential therapeutic opportunities for rheumatoid arthritis.
Insights
Rheumatoid arthritis treatments may target key inflammatory pathways. Understanding interleukin-1 and tumor necrosis factor alpha signaling offers new therapeutic opportunities.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) pathogenesis involves complex cellular and molecular mechanisms.
- Interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF-α) are critical inflammatory cytokines in RA.
- Targeting these cytokines presents a significant therapeutic challenge.
Purpose of the Study:
- To identify and characterize intracellular signaling pathways linked to IL-1 and TNF-α in RA.
- To explore potential therapeutic targets within these pathways.
- To understand the cross-talk between key signaling cascades.
Main Methods:
- Analysis of cellular and molecular mechanisms in rheumatoid arthritis.
- Identification and characterization of intracellular signaling pathways.
- Focus on mitogen-activated protein kinase (MAPK) and nuclear factor kappaB (NF-κB) pathways.
Main Results:
- IL-1 and TNF-α play crucial roles in RA.
- Specific intracellular signaling pathways, including MAPK and NF-κB, are associated with these cytokines.
- Cross-talk between MAPK and NF-κB pathways identified.
Conclusions:
- The identified signaling pathways represent potential therapeutic targets for RA.
- Targeting intracellular signaling offers a promising strategy for RA treatment.
- Further research into pathway modulation could lead to novel RA therapies.
Related Concept Videos
Intracellular Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Intracellular Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...


